Partial and full agonists of A1 adenosine receptors

Details for Australian Patent Application No. 2004209986 (hide)

International Classifications

Event Publications

25 August 2005 PCT application entered the National Phase

PCT publication WO2004/069185 Priority application(s): WO2004/069185

22 January 2009 Application Accepted

Published as AU-B-2004209986

23 April 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 23 Mar 2009. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000

20 August 2009 Standard Patent Sealed

15 October 2009 Amendment Made

The nature of the amendment is: Amend the patentee name from CV Therapeutics, Inc. to Gilead Palo Alto, Inc.

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.